Statements (63)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:can_be_used_to |
elevated calcium levels
|
| gptkbp:can_detect |
immunofixation electrophoresis
|
| gptkbp:can_lead_to |
bone lesions
|
| gptkbp:can_progress_to |
gptkb:active_multiple_myeloma
|
| gptkbp:diagnosis |
variable
serum protein electrophoresis |
| gptkbp:displacement |
monoclonal gammopathy of undetermined significance
|
| gptkbp:has_achieved |
renal impairment
|
| https://www.w3.org/2000/01/rdf-schema#label |
smoldering multiple myeloma
|
| gptkbp:is_a |
precursor disease
|
| gptkbp:is_associated_with |
gptkb:anemia
patient quality of life increased surveillance long-term monitoring plasma cell proliferation increased risk of progression |
| gptkbp:is_characterized_by |
low risk of complications
absence of end-organ damage monoclonal protein in blood no symptoms of myeloma stable disease state |
| gptkbp:is_common_in |
gptkb:African_Americans
|
| gptkbp:is_considered |
a benign condition
a clinical entity a non-active phase a precursor to multiple myeloma a stage of myeloma a watchful waiting scenario |
| gptkbp:is_evaluated_by |
imaging studies
clinical assessment risk stratification patient history bone marrow biopsy clinical trials for progression |
| gptkbp:is_linked_to |
genetic mutations
treatment decisions chronic inflammation treatment options immune system changes |
| gptkbp:is_managed_by |
watchful waiting
hematologists |
| gptkbp:is_monitored_by |
regular blood tests
symptom development |
| gptkbp:is_noted_for |
high serum M-protein levels
low risk of immediate treatment |
| gptkbp:is_part_of |
hematologic malignancies
cancer care continuum cancer patient care hematologic oncology myeloma management strategies myeloma spectrum disorders |
| gptkbp:is_recognized_by |
high light chain levels
|
| gptkbp:is_related_to |
plasma cell dyscrasia
|
| gptkbp:is_studied_in |
oncology research
|
| gptkbp:occurs_in |
other plasma cell disorders
|
| gptkbp:requires |
patient education
clinical trials |
| gptkbp:risk_factor |
age over 65
|
| gptkbp:symptoms |
asymptomatic
|
| gptkbp:treatment |
observation
|
| gptkbp:bfsParent |
gptkb:Oncology
|
| gptkbp:bfsLayer |
4
|